889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo

• Patrick Franken,
• Esther Breij,
• Kristel Kemper,
• Rieneke van de Ven,
• Sonja Ganzevles,
• Myrthe Veth,
• Ruud Brakenhoff

Affiliations

Patrick Franken

Genmab, Princeton, NJ, USA

Esther Breij

2Genmab A/S, Utrecht, Netherlands

Kristel Kemper

Genmab, Utrecht, Netherlands

Rieneke van de Ven

1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands

Sonja Ganzevles

1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands

Myrthe Veth

1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands

Ruud Brakenhoff

1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands